Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study

Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study

ObjectiveAlthough pegylated interferon α-2b (PEG-IFN α-2b) therapy for chronic hepatitis B has received increasing attention, determining the optimal treatment course remains challenging. This research aimed to develop an efficient model for predicting interferon (IFN) treatment course.MethodsPatien...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei Yan, Fei Tang, Jing Chen, YiCheng Lin, XinYu Chen, Qin Du, WeiLi Yin, Jing Liang, Lei Liu, Fang Wang, BaiGuo Xu, Qing Ye, HuiLing Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
chronic hepatitis B (CHB)
clinical cure
hepatitis b surface antigen (HBsAg)
PEG-IFN α
model
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1528758/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items